{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:06:33Z","timestamp":1786975593209,"version":"build-2736575974"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.0107","type":"journal-article","created":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T11:31:13Z","timestamp":1582716673000},"page":"e200107","source":"Crossref","is-referenced-by-count":37,"title":["Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation"],"prefix":"10.1001","volume":"3","author":[{"given":"Keith A. A.","family":"Fox","sequence":"first","affiliation":[{"name":"Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Velentgas","sequence":"additional","affiliation":[{"name":"Aetion Inc, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. John","family":"Camm","sequence":"additional","affiliation":[{"name":"Cardiology Clinical Academic Group Molecular & Clinical Sciences Research Institute, St George's University of London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Bassand","sequence":"additional","affiliation":[{"name":"Thrombosis Research Institute, London, United Kingdom"},{"name":"University of Besan\u00e7on, Besan\u00e7on, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Fitzmaurice","sequence":"additional","affiliation":[{"name":"University of Warwick Medical School, Coventry, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard J.","family":"Gersh","sequence":"additional","affiliation":[{"name":"Mayo Clinic College of Medicine, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Z.","family":"Goldhaber","sequence":"additional","affiliation":[{"name":"Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Goto","sequence":"additional","affiliation":[{"name":"Tokai University, Isehara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Haas","sequence":"additional","affiliation":[{"name":"Formerly Department of Medicine, Technical University of Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Misselwitz","sequence":"additional","affiliation":[{"name":"Bayer HealthCare Pharmaceuticals, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen S.","family":"Pieper","sequence":"additional","affiliation":[{"name":"Thrombosis Research Institute, London, United Kingdom"},{"name":"Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander G. G.","family":"Turpie","sequence":"additional","affiliation":[{"name":"McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freek W. A.","family":"Verheugt","sequence":"additional","affiliation":[{"name":"Onze Lieve Vrouwe Gasthuis (OLVG), Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Dabrowski","sequence":"additional","affiliation":[{"name":"Aetion Inc, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyi","family":"Luo","sequence":"additional","affiliation":[{"name":"Aetion Inc, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liza","family":"Gibbs","sequence":"additional","affiliation":[{"name":"Aetion Inc, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay K.","family":"Kakkar","sequence":"additional","affiliation":[{"name":"Thrombosis Research Institute, London, United Kingdom"},{"name":"University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the GARFIELD-AF Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,2,26]]},"reference":[{"issue":"38","key":"zoi200012r1","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS.","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"issue":"1","key":"zoi200012r2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.","volume":"74","author":"January","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"zoi200012r3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation.","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"issue":"7","key":"zoi200012r4","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1161\/CIRCULATIONAHA.111.060061","article-title":"Use of the CHA(2)DS(2)-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation.","volume":"126","author":"Lane","year":"2012","journal-title":"Circulation"},{"issue":"5","key":"zoi200012r5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063479","article-title":"Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry.","volume":"8","author":"Kakkar","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"zoi200012r6","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1161\/CIRCULATIONAHA.113.002927","article-title":"Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.","volume":"128","author":"Steinberg","year":"2013","journal-title":"Circulation"},{"issue":"6","key":"zoi200012r7","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1093\/eurheartj\/ehx730","article-title":"Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry.","volume":"39","author":"Verheugt","year":"2018","journal-title":"Eur Heart J"},{"issue":"12","key":"zoi200012r8","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/j.amjmed.2019.06.008","article-title":"Outcomes in newly diagnosed atrial fibrillation and history of acute coronary syndromes: insights from GARFIELD-AF.","volume":"132","author":"Verheugt","year":"2019","journal-title":"Am J Med"},{"issue":"11","key":"zoi200012r9","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/S1474-4422(07)70264-8","article-title":"Atrial fibrillation and stroke prevention.","volume":"6","author":"Lip","year":"2007","journal-title":"Lancet Neurol"},{"issue":"10","key":"zoi200012r10","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/nrcardio.2011.112","article-title":"The role of aspirin for stroke prevention in atrial fibrillation.","volume":"8","author":"Lip","year":"2011","journal-title":"Nat Rev Cardiol"},{"issue":"16","key":"zoi200012r11","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","article-title":"The 2018 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.","volume":"39","author":"Steffel","year":"2018","journal-title":"Eur Heart J"},{"issue":"2","key":"zoi200012r12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS guidelines on myocardial revascularization.","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"issue":"1","key":"zoi200012r13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ahj.2011.09.011","article-title":"International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD).","volume":"163","author":"Kakkar","year":"2012","journal-title":"Am Heart J"},{"issue":"20","key":"zoi200012r14","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"zoi200012r15","first-page":"114","article-title":"Evolving quality standards for large-scale registries: the GARFIELD-AF experience.","volume":"3","author":"Fox","year":"2017","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"5","key":"zoi200012r16","doi-asserted-by":"publisher","first-page":"917","DOI":"10.2337\/dci18-0007","article-title":"Economic costs of diabetes in the U.S. in 2017.","volume":"41","author":"American Diabetes Association","year":"2018","journal-title":"Diabetes Care"},{"issue":"1","key":"zoi200012r17","doi-asserted-by":"publisher","first-page":"162","DOI":"10.2337\/dc07-9917","article-title":"Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.","volume":"30","author":"Buse","year":"2007","journal-title":"Diabetes Care"},{"issue":"6","key":"zoi200012r18","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1161\/CIRCULATIONAHA.118.035012","article-title":"Early risks of death, stroke\/systemic embolism, and major bleeding in patients with newly diagnosed atrial fibrillation.","volume":"139","author":"Bassand","year":"2019","journal-title":"Circulation"},{"issue":"2","key":"zoi200012r19","doi-asserted-by":"publisher","first-page":"e531S","DOI":"10.1378\/chest.11-2304","article-title":"Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.","volume":"141","author":"You","year":"2012","journal-title":"Chest"},{"issue":"1","key":"zoi200012r20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/joim.12001","article-title":"Managing anticoagulation for atrial fibrillation: current issues and future strategies.","volume":"273","author":"John Camm","year":"2013","journal-title":"J Intern Med"},{"issue":"19","key":"zoi200012r21","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1001\/jama.288.19.2441","article-title":"Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis.","volume":"288","author":"van Walraven","year":"2002","journal-title":"JAMA"},{"issue":"4","key":"zoi200012r22","article-title":"Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack.","volume":"18","author":"Saxena","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"9526","key":"zoi200012r23","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W): a randomised controlled trial.","volume":"367","author":"Connolly","year":"2006","journal-title":"Lancet"},{"issue":"12","key":"zoi200012r24","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"issue":"3","key":"zoi200012r25","article-title":"Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks.","volume":"3","author":"Aguilar","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"9586","key":"zoi200012r26","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"issue":"12","key":"zoi200012r27","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1136\/hrt.2007.135657","article-title":"Warfarin for the prevention of systemic embolism in patients with non-valvular atrial fibrillation: a meta-analysis.","volume":"94","author":"Andersen","year":"2008","journal-title":"Heart"},{"issue":"3","key":"zoi200012r28","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1160\/TH08-08-0499","article-title":"How effective are dose-adjusted warfarin and aspirin for the prevention of stroke in patients with chronic atrial fibrillation? an analysis of the UK General Practice Research Database.","volume":"101","author":"Rietbrock","year":"2009","journal-title":"Thromb Haemost"},{"issue":"6","key":"zoi200012r29","first-page":"1106","article-title":"Treatments for stroke prevention in atrial fibrillation: a network meta-analysis and indirect comparisons versus dabigatran etexilate.","volume":"104","author":"Roskell","year":"2010","journal-title":"Thromb Haemost"},{"issue":"9","key":"zoi200012r30","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation.","volume":"364","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"issue":"5","key":"zoi200012r31","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/CRD.0000000000000088","article-title":"Non-vitamin K antagonist oral anticoagulants and antiplatelet therapy for stroke prevention in patients with atrial fibrillation: a meta-analysis of randomized controlled trials.","volume":"24","author":"Kumar","year":"2016","journal-title":"Cardiol Rev"},{"issue":"16","key":"zoi200012r32","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/archinternmed.2010.271","article-title":"Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation.","volume":"170","author":"Hansen","year":"2010","journal-title":"Arch Intern Med"},{"issue":"10","key":"zoi200012r33","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.112.114967","article-title":"Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study.","volume":"126","author":"Lamberts","year":"2012","journal-title":"Circulation"},{"issue":"11","key":"zoi200012r34","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.jacc.2013.05.029","article-title":"Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.","volume":"62","author":"Lamberts","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"zoi200012r35","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1161\/CIRCULATIONAHA.113.004834","article-title":"Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study.","volume":"129","author":"Lamberts","year":"2014","journal-title":"Circulation"},{"issue":"25","key":"zoi200012r36","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1016\/j.jacc.2016.03.581","article-title":"Aspirin instead of oral anticoagulant prescription in atrial fibrillation patients at risk for stroke.","volume":"67","author":"Hsu","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"zoi200012r37","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1093\/eurheartj\/eht445","article-title":"Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial.","volume":"35","author":"Alexander","year":"2014","journal-title":"Eur Heart J"},{"issue":"2","key":"zoi200012r38","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002587","article-title":"Concomitant use of single antiplatelet therapy with edoxaban or warfarin in patients with atrial fibrillation: analysis from the ENGAGE AF-TIMI48 trial.","volume":"5","author":"Xu","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"zoi200012r39","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ahj.2016.05.019","article-title":"Use of concomitant aspirin in patients with atrial fibrillation: findings from the ROCKET AF trial.","volume":"179","author":"Shah","year":"2016","journal-title":"Am Heart J"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2761869\/fox_2020_oi_200012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T11:31:15Z","timestamp":1582716675000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2761869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,26]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2,5]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.0107","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,26]]}}}